Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen Sells 10,300 Shares of Stock
Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 10,300 shares on May 21 at an average $5.79, for about $59,637, under a Rule 10b5-1 plan, reducing his stake 5.10% to 191,838 shares. The article also notes a May 22 sale of 40,575 shares at $5.91. SRTA last reported May 6 quarterly EPS of $0.03 on $67.38M revenue.
How this was made
The 30-second read
Why it matters
The disclosure can affect short-term positioning and sentiment, especially for a higher-beta small-cap, but it does not provide new fundamentals beyond the ownership change.
Market read
For SRTA, the actionable element is insider selling under Rule 10b5-1 plus the stock’s recent earnings beat and analyst targets, which together shape near-term sentiment and volatility.
What to watch
The article also notes a recent earnings beat (EPS $0.03 vs -$0.04 consensus) and a $8.00 analyst target; those positives may offset the insider-selling optics.
Background
The piece reports officer insider transactions for Strata Critical Medical and summarizes recent trading and earnings context.
Ticker impact
SRTA CAO Amir Cohen sold 10,300 shares (and another 40,575 the next day) under a Rule 10b5-1 plan, signaling insider selling activity.
Likely modest downside bias or volatility around the disclosure; larger moves would require follow-through from earnings/forward guidance.
The article is an SEC Form 4-style ownership-change disclosure for SRTA, with sales at ~$5.79 and ~$5.91 and a noted 5.10% ownership reduction; however, Rule 10b5-1 implies pre-planned execution rather than new negative information.
Market effects
Limited direct read-across; this is company-specific insider selling rather than an industry catalyst.
None indicated beyond typical small-cap US liquidity effects.
None indicated.
Counterpoint
Because the sales were executed under a pre-arranged Rule 10b5-1 plan, the activity may be routine rebalancing rather than a bearish signal.
Key entities
- companyStrata Critical Medical
SRTA insider selling disclosure: CAO Amir Cohen sold shares under a Rule 10b5-1 plan.
- personAmir Cohen
Chief Accounting Officer whose SEC-disclosed sales reduced his ownership by 5.10%.
